Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma

Cancer

Volumn 91, Issue 5, 2001, Pages 972-982

  Fröhlich, Eleonore ^a   Schlagenhauff, Bettina ^b   Möhrle, Matthias ^c   Weber, Ekkehard ^d   Klessen, Christian ^a   Rassner, Gernot ^c  

^a Anatomisches Institut   (Germany)

^b Swissana Clinic   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d Physiologisch Chemisches Institut   (Germany)

Author keywords

Activity; Cathepsin; Histochemistry; Immunocytochemistry; In situ hybridization; Protease; Tumor

Indexed keywords

CATHEPSIN; CATHEPSIN B; CATHEPSIN D; CATHEPSIN H; CATHEPSIN L; PROTEINASE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MELANOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RNA TRANSCRIPTION;

EID: 0035281687     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010301)91:5<972::AID-CNCR1087>3.3.CO;2-H     Document Type: Article

References (57)

1. Collagenase secretion by human breast neoplasms: A clinicopathologic investigation
2. Proteolytic enzymes and plasminogen activator in melanoma
3. Stromelysin in tumor progression and metastasis
4. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers
5. Cathepsin H activity in the human brain and human brain neoplasms
6. Cathepsin B and L activities in gastric cancer tissue: Correlation with histological findings
7. Increased cathepsin B activity in human lung tumors
8. Activity of cathepsin D in some neoplasms of the gastrointestinal tract
9. Cystatins and cathepsins in breast cancer
10. Proteolytic lysosomal enzymes in ovarian cancer
11. Cathepsin D content in colorectal cancer. Correlation with cathepsin D activity and other biological parameters: A preliminary, report
12. Expression of cathepsin D and B in invasion and metastasis of squamous cell carcinoma
13. Cathepsin D in primary squamous laryngeal tumors: Correlation with clinico-pathological parameters and receptor status
14. Cathepsin D in normal and neoplastic thyroid tissues
15. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival
16. Immunohistochemical analysis of cathepsin D in prostate carcinoma
17. Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer
18. Cathepsin D in tissue and serum of patients with squamous cell carcinoma of the head and neck
19. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma
20. Expression of cathepsin D during the progression of human gliomas
21. Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas
22. Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer
23. Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells
24. Enhanced expression of cathepsin L in metastatic bone tumors
25. Marked increases in cathepsin B and L activities distinguish papillary carcinoma of the thyroid from normal thyroid or thyroid with non-neoplastic disease
26. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue
27. Concentrations of lysosomal cysteine proteases are decreased in renal cell carcinoma compared with normal kidney
28. Lysosomal cathepsin B: Correlation with metastatic potential
29. Expression of cathepsin D in primary and metastatic human melanoma and dysplastic nevi
30. The expression of proteolytic enzymes at the dermal invading front of primary cutaneous melanoma predicts metastasis
31. Biochemical and immunohistochemical analysis of cathepsin B, H, L and D in human melanotic tumours
32. Prognostic value of cathepsins B, D and steffins A and B in laryngeal carcinoma
33. Stefin B, the major low molecular weight inhibitor in ovarian carcinoma
34. Cysteine proteinase activity in arthritic rat knee joints and the effects of a selective systemic inhibitor, Z-Phe-AlaCH2F
35. A selective colorimettic assay for cathepsin L using Z-Phe-Arg-4-methoxy-betanaphthylamide
36. Immunohistochemical and clinical evaluation of cathepsin expression in soft tissue sarcomas
37. Monoclonal antibodies against cathepsin L and procathepsin L of different species
38. Epidemiology of malignant melanoma in central Europe: Risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society
39. Primary cutaneous malignant melanoma
40. Role and behavior of cathepsin B and cathepsin L in gastric cancer
41. Elevation of tissue cathepsin B and L activities in gastric cancer
42. Cathepsin B, L, and D activities in colorectal carcinomas: Relationship with clinico-pathological parameters
43. Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer
44. Stefins and lysosomal cathepsins B, L and D in human breast carcinoma
45. Cathepsins D, B and L in breast carcinoma and in transformed human breast epithelial cells (HBEC)
46. Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis
47. Demonstration of proteases in basal cell carcinomas: A histochemical study using amino acid-4-methoxy-2-naphthyl-amides as chromogenic substrates
48. Stromal cell cathepsin D expression and long-term survival in breast cancer
49. Immunohistochemical localization of cathepsins D and E in human gastric cancer: A possible correlation with local invasive and metastatic activities of carcinoma cells
50. Identification of cystatin B in human esophageal carcinoma, using differential displays in which the gene expression is related to lymph-node metastasis
51. Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors
52. Characterization of the cathepsin B gene and multiple mRNAs in human tissues evidence for alternative splicing of cathepsin B pre-mRNA
53. Transcriptional regulation of cathepsin B expression in B16 melanomas of varying metastatic potential
54. Tumor heterogeneity and the biology of cancer invasion and metastasis
55. Cathepsin B: Association with plasma membrane in metastatic tumors
56. Membrane-associated cathepsin L: A role in metastasis of melanomas
57. Immunelectron microscopic localization of cathepsin B in human exocrine glands